Craft

Genetic Technologies

Stock Price

$0

2024-10-08

Market Capitalization

$4 M

2024-10-08

Revenue

$7.7 M

FY, 2024

Genetic Technologies Summary

Company Summary

Overview
Genetic Technologies is a molecular diagnostics company that develops and commercializes genetic risk assessment technology. The company offers predictive testing and assessment tools to empower physicians to manage patient health and individuals and reduce their risk of contracting cancer and other chronic diseases. Its products include GeneType tests that can determine the risk of developing sporadic breast cancer and colorectal cancer.
Type
Public
Status
Active
Founded
1989
HQ
Fitzroy, AU | view all locations
Website
https://www.gtglabs.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Richard Allman

    Richard Allman, Chief Scientific Officer

    LocationsView all

    2 locations detected

    • Fitzroy, VIC HQ

      Australia

      60-66 Hanover St

    • Charlotte, NC

      United States

      1300 Baxter St #157

    Genetic Technologies Financials

    Summary Financials

    Revenue (H1, 2025)
    $3.4M
    Gross profit (H1, 2025)
    $3.8M
    Net income (H1, 2025)
    ($4.1M)
    Cash (H1, 2025)
    $1.0M
    EBIT (H1, 2025)
    ($2.4M)
    Enterprise value
    $3.5M

    Footer menu